Superficial epidermolytic ichthyosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:455OMIM:146800Q80.8
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Superficial epidermolytic ichthyosis (SEI), also known as ichthyosis bullosa of Siemens (IBS), is a rare genetic skin disorder characterized by superficial blistering and hyperkeratosis (thickening of the outer layer of the skin). It is caused by mutations in the KRT2 gene (keratin 2), which encodes a protein expressed in the upper layers of the epidermis (suprabasal keratinocytes of the granular layer). Because the defective keratin is expressed more superficially in the skin compared to classic epidermolytic ichthyosis, the blistering in SEI tends to be milder and more superficial, with characteristic "mauserung" — a distinctive shedding or molting phenomenon where sheets of superficial skin peel off, particularly over the limbs. Clinical features typically present at birth or in early infancy with episodes of skin fragility, superficial blistering, and peeling. Over time, the blistering tendency may decrease while mild to moderate dark (hyperkeratotic) scaling develops, predominantly affecting the limbs, particularly the shins and flexural areas. The palms and soles are generally spared. The condition is generally milder than classic epidermolytic ichthyosis (caused by KRT1 or KRT10 mutations), and widespread erythroderma is typically absent. Histologically, the skin shows epidermolytic hyperkeratosis confined to the granular and upper spinous layers. There is no cure for superficial epidermolytic ichthyosis. Treatment is symptomatic and supportive, focusing on skin care with regular use of emollients and keratolytic agents (such as urea-based or lactic acid-based creams) to reduce scaling and improve skin texture. Avoidance of excessive heat and friction can help minimize blistering episodes. Retinoids may be considered in more severe cases but must be used cautiously due to potential side effects. Genetic counseling is recommended for affected individuals and their families.

Also known as:

Clinical phenotype terms— hover any for plain English:

AcantholysisHP:0100792
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Superficial epidermolytic ichthyosis.

View clinical trials →

No actively recruiting trials found for Superficial epidermolytic ichthyosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Superficial epidermolytic ichthyosis community →

Specialists

15 foundView all specialists →
YM
Yoshinao Muro
Specialist
1 Superficial epidermolytic ichthyosis publication
YS
Yasushi Suga
Specialist
1 Superficial epidermolytic ichthyosis publication
IV
Igor Vázquez-Osorio
Specialist
1 Superficial epidermolytic ichthyosis publication
NM
Noelia Moreiras-Arias
Specialist
1 Superficial epidermolytic ichthyosis publication
PP
Patricia Pérez-Feal
Specialist
1 Superficial epidermolytic ichthyosis publication
LS
Laura Sainz-Gaspar
Specialist
1 Superficial epidermolytic ichthyosis publication
NO
Nelmar Valentina Ortiz-Cabrera
Specialist
1 Superficial epidermolytic ichthyosis publication
AH
Angela Hernández-Martín
Specialist
1 Superficial epidermolytic ichthyosis publication
YS
Yuika Suzuki
Specialist
1 Superficial epidermolytic ichthyosis publication
TT
Takuya Takeichi
Specialist
1 Superficial epidermolytic ichthyosis publication
KT
Kana Tanahashi
Specialist
1 Superficial epidermolytic ichthyosis publication
TO
Tomoo Ogi
Specialist
1 Superficial epidermolytic ichthyosis publication
MA
Masashi Akiyama
Specialist
1 Superficial epidermolytic ichthyosis publication
CW
Chen Wang
Specialist
1 Superficial epidermolytic ichthyosis publication
CP
Chaolan Pan
Specialist
1 Superficial epidermolytic ichthyosis publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Superficial epidermolytic ichthyosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Superficial epidermolytic ichthyosisForum →

No community posts yet. Be the first to share your experience with Superficial epidermolytic ichthyosis.

Start the conversation →

Latest news about Superficial epidermolytic ichthyosis

No recent news articles for Superficial epidermolytic ichthyosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Superficial epidermolytic ichthyosis

What is Superficial epidermolytic ichthyosis?

Superficial epidermolytic ichthyosis (SEI), also known as ichthyosis bullosa of Siemens (IBS), is a rare genetic skin disorder characterized by superficial blistering and hyperkeratosis (thickening of the outer layer of the skin). It is caused by mutations in the KRT2 gene (keratin 2), which encodes a protein expressed in the upper layers of the epidermis (suprabasal keratinocytes of the granular layer). Because the defective keratin is expressed more superficially in the skin compared to classic epidermolytic ichthyosis, the blistering in SEI tends to be milder and more superficial, with char

How is Superficial epidermolytic ichthyosis inherited?

Superficial epidermolytic ichthyosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Superficial epidermolytic ichthyosis typically begin?

Typical onset of Superficial epidermolytic ichthyosis is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Superficial epidermolytic ichthyosis?

15 specialists and care centers treating Superficial epidermolytic ichthyosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.